The LYMErix™ Story: FDA Approval to Market Withdrawal ─ Learning from History
This is a piece on the Lymerix Vaccine controversy, written by Patricia V. Smith, President, Lyme Disease Association, Inc., in 2013 and published on LDA website.
2013 version published on LDA website
It was published in the Lyme Times Special Issue Sept. 2018 The LYMErix™ Story: FDA Approval to Market Withdrawal ─ Learning from History
2018 version published in Lyme Times
Click here for FDA Powerpoint on the Vaccine Adverse Events System and LymeRix